Artificial Intelligence

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

Reaching over 90% of German mobile users, a new partnership aims to restore trust in the phone by displaying verified business names on incoming calls.

After a volatile market debut, the supersonic flight company hits the NYSE, signaling a new era for high-speed testing and air-launch services.

SpeedBuilder Systems hires Marcel Bagley, a veteran from Guidewire and DXC, to accelerate growth for its BindExpress Suite in the competitive P&C market.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

AmpliTech launches mid-band 5G radios, aiming to accelerate Open RAN adoption and capture a slice of the booming private network and smart city market.

New data shows an AI-driven approach is enrolling IBD patients 3.4x faster, promising to accelerate the delivery of novel therapies to those in need.

With a new $50M facility from CIBC, Montreal-based AlayaCare is poised to accelerate its M&A strategy and advance its mission to digitize home care.

Appian flips from a major loss to GAAP profitability in 2025, driven by strong cloud revenue, key AI contracts, and a positive outlook for 2026.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Phemex is betting its future on becoming a fully AI-native platform. Is this a marketing ploy or the beginning of a new standard for all crypto exchanges?

Emirates Health Services launches 'Amal,' the UAE's first AI physician assistant, aiming to enhance patient care and streamline clinical workflows.

China's MOMOTOY brings its AI-powered, emotionally intelligent art toys to the U.S., aiming to redefine collectibles with personality and connection.

The DoD awards a pivotal contract to Stratolaunch, leveraging its reusable Talon-A vehicle to accelerate high-speed flight testing and close the gap on rivals.

An international team, backed by a $2M grant from a global consortium and Microsoft, will use AI to personalize care for a long-overlooked disease.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.